| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238123.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.045486457 |
Resistant |
| ENSG00000238123.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.024294281 |
Resistant |
| ENSG00000238123.1 |
Tanespimycin |
Colon adenocarcinoma |
0.030424323 |
Sensitive |
